These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
324 related articles for article (PubMed ID: 31880399)
21. The phosphoinositide 3-kinase α selective inhibitor BYL719 enhances the effect of the protein kinase C inhibitor AEB071 in GNAQ/GNA11-mutant uveal melanoma cells. Musi E; Ambrosini G; de Stanchina E; Schwartz GK Mol Cancer Ther; 2014 May; 13(5):1044-53. PubMed ID: 24563540 [TBL] [Abstract][Full Text] [Related]
22. Comprehensive clinical imaging, histopathological analysis and liquid biopsy-based surveillance of human uveal melanoma in a prolonged rabbit xenograft model. Bustamante P; Coblentz J; Mastromonaco C; Youhnovska E; Ito H; Proença RP; Fonseca C; Dickinson K; Marcotte E; MacDonald M; Toledo-Dias AB; Bergeron S; Goyeneche A; Schmidt Andujar RA; Tsering T; Laskaris A; Jin E; Nadeau A; Porraccio T; Burnier MN; Burnier JV Melanoma Res; 2024 Aug; 34(4):285-295. PubMed ID: 38847739 [TBL] [Abstract][Full Text] [Related]
23. An orthotopic model for human uveal melanoma in SCID mice. Mueller AJ; Maniotis AJ; Freeman WR; Bartsch DU; Schaller UC; Bergeron-Lynn G; Cheng L; Taskintuna I; Chen X; Kan-Mitchell J; Folberg R Microvasc Res; 2002 Sep; 64(2):207-13. PubMed ID: 12204644 [TBL] [Abstract][Full Text] [Related]
24. Transcriptional inhibition by CDK7/9 inhibitor SNS-032 abrogates oncogene addiction and reduces liver metastasis in uveal melanoma. Zhang J; Liu S; Ye Q; Pan J Mol Cancer; 2019 Sep; 18(1):140. PubMed ID: 31526394 [TBL] [Abstract][Full Text] [Related]
25. MHC class II-transduced tumor cells originating in the immune-privileged eye prime and boost CD4(+) T lymphocytes that cross-react with primary and metastatic uveal melanoma cells. Bosch JJ; Thompson JA; Srivastava MK; Iheagwara UK; Murray TG; Lotem M; Ksander BR; Ostrand-Rosenberg S Cancer Res; 2007 May; 67(9):4499-506. PubMed ID: 17483366 [TBL] [Abstract][Full Text] [Related]
26. Metastatic uveal melanoma: biology and emerging treatments. Woodman SE Cancer J; 2012; 18(2):148-52. PubMed ID: 22453016 [TBL] [Abstract][Full Text] [Related]
27. Notch signaling promotes growth and invasion in uveal melanoma. Asnaghi L; Ebrahimi KB; Schreck KC; Bar EE; Coonfield ML; Bell WR; Handa J; Merbs SL; Harbour JW; Eberhart CG Clin Cancer Res; 2012 Feb; 18(3):654-65. PubMed ID: 22228632 [TBL] [Abstract][Full Text] [Related]
28. Modeling the behavior of uveal melanoma in the liver. Folberg R; Leach L; Valyi-Nagy K; Lin AY; Apushkin MA; Ai Z; Barak V; Majumdar D; Pe'er J; Maniotis AJ Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):2967-74. PubMed ID: 17591861 [TBL] [Abstract][Full Text] [Related]
29. A chicken embryo model to study the growth of human uveal melanoma. Luyten GP; Mooy CM; De Jong PT; Hoogeveen AT; Luider TM Biochem Biophys Res Commun; 1993 Apr; 192(1):22-9. PubMed ID: 8476423 [TBL] [Abstract][Full Text] [Related]
30. Targeting primary and metastatic uveal melanoma with a G protein inhibitor. Onken MD; Makepeace CM; Kaltenbronn KM; Choi J; Hernandez-Aya L; Weilbaecher KN; Piggott KD; Rao PK; Yuede CM; Dixon AJ; Osei-Owusu P; Cooper JA; Blumer KJ J Biol Chem; 2021; 296():100403. PubMed ID: 33577798 [TBL] [Abstract][Full Text] [Related]
31. Macrophage polarization contributes to the efficacy of an oncolytic HSV-1 targeting human uveal melanoma in a murine xenograft model. Liu S; Zhang J; Fang S; Zhang Q; Zhu G; Tian Y; Zhao M; Liu F Exp Eye Res; 2021 Jan; 202():108285. PubMed ID: 33039456 [TBL] [Abstract][Full Text] [Related]
33. Effect of Genistein on vasculogenic mimicry formation by human uveal melanoma cells. Cong R; Sun Q; Yang L; Gu H; Zeng Y; Wang B J Exp Clin Cancer Res; 2009 Sep; 28(1):124. PubMed ID: 19735546 [TBL] [Abstract][Full Text] [Related]
34. The pharmacological NF-κB inhibitor BAY11-7082 induces cell apoptosis and inhibits the migration of human uveal melanoma cells. Hu S; Luo Q; Cun B; Hu D; Ge S; Fan X; Chen F Int J Mol Sci; 2012 Nov; 13(12):15653-67. PubMed ID: 23443086 [TBL] [Abstract][Full Text] [Related]
35. Characterization of ocular and metastatic uveal melanoma in an animal model. Blanco PL; Marshall JC; Antecka E; Callejo SA; Souza Filho JP; Saraiva V; Burnier MN Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4376-82. PubMed ID: 16303923 [TBL] [Abstract][Full Text] [Related]
36. Natural withanolide withaferin A induces apoptosis in uveal melanoma cells by suppression of Akt and c-MET activation. Samadi AK; Cohen SM; Mukerji R; Chaguturu V; Zhang X; Timmermann BN; Cohen MS; Person EA Tumour Biol; 2012 Aug; 33(4):1179-89. PubMed ID: 22477711 [TBL] [Abstract][Full Text] [Related]
37. Preclinical evaluation of drug combinations identifies co-inhibition of Bcl-2/XL/W and MDM2 as a potential therapy in uveal melanoma. Decaudin D; Frisch Dit Leitz E; Nemati F; Tarin M; Naguez A; Zerara M; Marande B; Vivet-Noguer R; Halilovic E; Fabre C; Jochemsen A; Roman-Roman S; Alsafadi S Eur J Cancer; 2020 Feb; 126():93-103. PubMed ID: 31927215 [TBL] [Abstract][Full Text] [Related]
38. Methods for subchoroidal implantation of Greene melanoma in rabbits. Shikishima K Int J Clin Oncol; 2004 Apr; 9(2):79-84. PubMed ID: 15108038 [TBL] [Abstract][Full Text] [Related]
39. Establishment and characterization of human uveal malignant melanoma xenografts in nude mice. Heegaard S; Spang-Thomsen M; Prause JU Melanoma Res; 2003 Jun; 13(3):247-51. PubMed ID: 12777978 [TBL] [Abstract][Full Text] [Related]